Should we be targeting sleep architecture to more effectively treat schizophrenia?

JAAPA. 2018 Dec;31(12):52-54. doi: 10.1097/01.JAA.0000544303.53824.71.

Abstract

The sleep architecture (or sleep kinetics) of schizophrenia is different from that of other mental illnesses, including major depressive disorder. However, clinicians rarely consider these parameters in clinical settings during treatment. This article discusses the use of polysomnography to characterize the sleeping patterns of patients diagnosed with schizophrenia and the positive influence of clozapine on sleep in patients with schizophrenia.

Publication types

  • Review

MeSH terms

  • Antipsychotic Agents / pharmacology
  • Antipsychotic Agents / therapeutic use
  • Clozapine / pharmacology
  • Clozapine / therapeutic use
  • Humans
  • Polysomnography
  • Schizophrenia / therapy*
  • Schizophrenic Psychology*
  • Sleep / drug effects
  • Sleep / physiology*
  • Sleep Stages / drug effects
  • Sleep Stages / physiology

Substances

  • Antipsychotic Agents
  • Clozapine